Interpace Biosciences Inc Kurs / Umsatz
Was ist das Kurs / Umsatz von Interpace Biosciences Inc?
Kurs / Umsatz von Interpace Biosciences Inc ist 0.12
Was ist die Definition von Kurs / Umsatz?
Das Kurs-Umsatz-Verhältnis ist der Aktienkurs eines Unternehmens im Vergleich zu seinen Einnahmen.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Kurs / Umsatz von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Interpace Biosciences Inc
Was macht Interpace Biosciences Inc?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Unternehmen mit kurs / umsatz ähnlich Interpace Biosciences Inc
- Suryalakshmi Cotton Mills hat Kurs / Umsatz von 0.12
- Ishaan Infrastructures and Shelters hat Kurs / Umsatz von 0.12
- Booktopia hat Kurs / Umsatz von 0.12
- Belgian Resources and Capital hat Kurs / Umsatz von 0.12
- NWF plc hat Kurs / Umsatz von 0.12
- TVA hat Kurs / Umsatz von 0.12
- Interpace Biosciences Inc hat Kurs / Umsatz von 0.12
- Master Glory hat Kurs / Umsatz von 0.12
- MediPal hat Kurs / Umsatz von 0.12
- Kiaro Corp hat Kurs / Umsatz von 0.12
- Delek US Inc hat Kurs / Umsatz von 0.12
- mutares AG hat Kurs / Umsatz von 0.12
- Hilton Food Plc hat Kurs / Umsatz von 0.12